In Brief: Immunomedics LeukoScan
Executive Summary
Immunomedics LeukoScan: BLA submitted to FDA Dec. 19 for radio-labeled monoclonal antibody fragment for the detection of osteomyelitis in long bones and in patients with diabetic foot ulcers, and for use in patients with right lower quadrant disease, particularly for detection of acute atypical appendicitis...